Skip to content

EFFECT OF PROPHYLAXIS FOR DEEP VENOUS THROMBOSIS IN TRAUMATIC SPINAL CORD INJURY

EFFECT OF PROPHYLAXIS FOR DEEP VENOUS THROMBOSIS IN TRAUMATIC SPINAL CORD INJURY - DVTSCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036432
Enrollment
100
Registered
2019-05-01
Start date
2016-11-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DEEP VENOUS THROMBOSIS IN TRAUMATIC SPINAL CORD INJURY

Interventions

Intervention(n=50): Subcutaneous low molecular weight heparin (enoxaparin 40 mg/day) given for 2 months Physiotherapy of all joints Massage Control(n=50): Physiotherapy of all jo

Sponsors

Central Institute of Orthopaedics(CIO), Safdarjung Hospital and VMMC, New Delhi-110029
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Cervical spinal cord injury patient with quadriplegia 2. Thoracolumbar spinal cord injury with paraplegia 3. Age >18 years

Exclusion criteria

Exclusion criteria: 1. Incomplete spinal cord injury patient 2. Spinal cord injury without neurological deficit 3. Pathological fractures of the spine 4. Congenital deformity of the spine 5. Localised infection in extremities 6. Derranged PT/INR Values

Design outcomes

Primary

MeasureTime frame
Patients clinical assessment for DVT using WELL SCORE along with d dimer assay every, 2 weeks after getting into either study or control group. USG doppler to rule out DVT (considered the gold standard in the study).

Countries

Asia(except Japan)

Contacts

Public ContactDr Abhishek Tiwari

Safdarjung Hospital and Vardhman Mahavir Medical College, MoHFW, GoI Central Institute of Orthopaedics(CIO)

abhishekkt90@gmail.com+911126192467

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026